Asarfi Hospital Share Price
197.40+1.00 (+0.51%)
+64.77% past 1 Year
Asarfi Hospital Limited is an integrated healthcare service provider, committed to deliver valued healthcare services to its patients that includes prevention, treatment and proper rehabilitation. Asarfi Hospital is many bedded
Corporate filings & documents
Announcements
We hereby inform you that the meeting of the Board of Directors of Asarfi Hospital Limited was held on Tuesday August 25 2026 at 11:00 A.M. at the registered office of the Company at 4th Floor Asarfi Hospital Baramuri B. Polytechnic Dhanbad - 828130
1 week agoWe hereby inform you that the meeting of the Board of Directors of Asarfi Hospital Limited was held on Tuesday August 25 2026 at 11:00 A.M. at the registered office of the Company at 4th Floor Asarfi Hospital Baramuri B. Polytechnic Dhanbad - 828130
1 week agoAsarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 inter alia to consider and approve Notice is hereby given that the 4th Meeting of the Board of Directors of Asarfi Hospital Limited for FY 2026-27 will be held on Tuesday 25 August 2026 at 11:00 A.M. at the Registered Office of the Company at Baramuri Bishunpur Polytechnic Dhanbad Jharkhand- 828130.
2 weeks agoSubmission of Newspaper Advertisement of unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30 2026.
3 weeks agoSubmission of Newspaper Advertisement of unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30 2026.
3 weeks agoIntimation Under Regulation 30 of the SEBI (Listing obligation and Disclosure Requirements) Regulations 2015- Submission of Press Release/ Media Release.
3 weeks agoIntimation Under Regulation 30 of the SEBI (Listing obligation and Disclosure Requirements) Regulations 2015- Submission of Press Release/ Media Release.
3 weeks agoWe hereby submit the Investor Presentation for the Qtr ended 30th June 2026.
3 weeks agoWe hereby submit the Investor Presentation for the Qtr ended 30th June 2026.
3 weeks agoWe wish to inform you that the board of Director of Asarfi Hospital Limited at its meeting held today i.e 07 August 2026 has considered and approved the unaudited standalone and consolidated financial results of the company for the quarter ended 30 June 2026.
3 weeks agoWe wish to inform you that the board of Director of Asarfi Hospital Limited at its meeting held today i.e 07 August 2026 has considered and approved the unaudited standalone and consolidated financial results of the company for the quarter ended 30 June 2026.
3 weeks agoWe wish to inform you that the Board of Directors of Asarfi Hospital Limited ("the Company") at its meeting held today i.e. 07 August 2026 has considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30 June 2026.
3 weeks agoWe wish to inform you that the Board of Directors of Asarfi Hospital Limited ("the Company") at its meeting held today i.e. 07 August 2026 has considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30 June 2026.
3 weeks agoAsarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve of the Unaudited Financial Results for the Quarter ended 30th June 2026.
1 month agoAsarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve of the Unaudited Financial Results for the Quarter ended 30th June 2026.
1 month agoWe wish you to inform you that the management of Asarfi Hospital Limited Participated in Analyst/ Investor Webinar held on 24th July 2026 from 04:30 PM to 5:30 PM (IST).
1 month agoWe wish you to inform you that the management of Asarfi Hospital Limited Participated in Analyst/ Investor Webinar held on 24th July 2026 from 04:30 PM to 5:30 PM (IST).
1 month agowe wish to inform you that the Company will participate in anAnalyst/Institutional Investor Meeting on dated July 24 2026.
1 month agowe wish to inform you that the Company will participate in anAnalyst/Institutional Investor Meeting on dated July 24 2026.
1 month agoWe hereby inform you that the Trading Window for dealing in the securities of the Company shall remain closed for all Designated persons and their Immediate Relative from July01 2026. The Trading window shall reopen 48 hours after the declaration of the Un Audited Financial Results of the Company for the Quarter ended June 30 2026.
2 months agoWe hereby inform you that the Trading Window for dealing in the securities of the Company shall remain closed for all Designated persons and their Immediate Relative from July01 2026. The Trading window shall reopen 48 hours after the declaration of the Un Audited Financial Results of the Company for the Quarter ended June 30 2026.
2 months agoWe wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday 27 June 2026 commenced at 3:00 P.M. and concluded at 7:30 P.M. inter alia considered and approved the following: 1. Approval to Participate in PPP Medical College Project 2. Approval for Furnishing Bid Security.
2 months agoWe wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Saturday 27 June 2026 commenced at 3:00 P.M. and concluded at 7:30 P.M. inter alia considered and approved the following: 1. Approval to Participate in PPP Medical College Project 2. Approval for Furnishing Bid Security.
2 months agoWe wish you to inform you for the year ended March 31 2026 There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each aggregating to Rs.26 93 60 000/-issued by the company for the object stated in the offer document.
3 months agoWe hereby submit the transcript of the earning conference call held on May 27 2026 wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ended March 31 2026.
3 months agoWe hereby submit the transcript of the earning conference call held on May 27 2026 wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ended March 31 2026.
3 months agoPursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation of our intimation dated May 21 2026 regarding the schedule of the Institutional Investor/Analyst Meet we hereby inform you that the Company participated in an Investor Meet (one-to-one meeting) organized by Chorus Call Conferencing Services (I) Pvt. Ltd. on May 27 2026 through a virtual platform.
3 months agoPursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation of our intimation dated May 21 2026 regarding the schedule of the Institutional Investor/Analyst Meet we hereby inform you that the Company participated in an Investor Meet (one-to-one meeting) organized by Chorus Call Conferencing Services (I) Pvt. Ltd. on May 27 2026 through a virtual platform.
3 months agoWith reference to our earlier intimation regarding the Analyst / Investor Meeting scheduled to be held on Monday May 25 2026 at 04:00 P.M. (IST) we wish to inform you that due tounavoidable reasons the said meeting has been rescheduled.The revised schedule of the Analyst / Investor Meeting is as under:Date: Wednesday May 27 2026Time: 04:00 P.M. (IST)The meeting will be held inter alia to discuss the Audited Financial Results of the Company for the quarter and financial year ended March 31 2026.
3 months agoWe wish to inform you that the Company has scheduled a Conference Call with Analysts / Investors on Monday May 25 2026 at 04:00 P.M. (IST) inter alia to discuss the Audited Financial Results of the Company for the quarter and financial year ended March 31 2026.
3 months agoWe herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March31 2026 for your kind information and record.
3 months agoWe herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March31 2026 for your kind information and record.
3 months agoWe herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March31 2026 for your kind information and record.
3 months agoWe herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March31 2026 for your kind information and record.
3 months agoIntimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 15 - Press Release Titled Extract of Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended March 31 2026.
3 months agoIntimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 15 - Press Release Titled Extract of Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended March 31 2026.
3 months agoInvestor Presentation of Asarfi Hospital Limited for the Quarter and Financial Year ended 31st March 2026.
3 months agoWe wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e Monday 11th May 2026 has inter alia considered and approved the standalone and consolidated financial Results of the company for the quarter and financial year ended 31st March 2026.
3 months agoWe wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e Monday 11th May 2026 has inter alia considered and approved the standalone and consolidated financial Results of the company for the quarter and financial year ended 31st March 2026.
3 months agoWe wish to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held today i.e. Monday 11th May 2026 has inter alia considered and approved the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March 2026.
3 months agoAsarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 inter alia to consider and approve Pursuant to the aforesaid regulation notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday 11th May 2026 inter alia to consider and approve the audited financial results of the Company for the financial year ended 31st March 2026
4 months agoIn term of the provision of the securities and Exchange Board of India (PIT) Regulation 2015 as amended from to time and Prohibition of Insider trading policy ("the Policy").The Trading Window for the dealing in the securities of the company will be closed for all designated person and their Immediate Relative from April01 2026 and the same will remain closed until 48 hours after the declaration of Audited Financial Result of the Company for the quarter ended and financial Year ended March 31 2026.
5 months agoOutcome of Press Release/Media Release Under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulation 2015.
6 months agoWith Reference the captioned subject Press Release / Media Release title Extract of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025.
6 months agoWe Submission the Investor Presentation of the Company for the quarter ended December 31 2025.
6 months agoWe wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e. 09-February26 has considered and approved the unaudited standalone and consolidated financial result of the company for the quarter ended 31 December25.
6 months agoWe wish to inform you that the Board of Directors of Asarfi Hospital Limited (the Company) at its meetingheld today i.e. 09 February 2026 has considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31st December 2025.
6 months agoAsarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Notice is hereby given that the 8th Meeting of the Board of Directors of Asarfi Hospital Limited to consider inter alia the Unaudited Financial Results for the Quarter Ended 31st December 2025 for the Financial Year 2025-26 will be held on Monday 9th February 2026 at 03:00 P.M. at the Registered Office of the Company.
7 months agoIntimation for closure of Trading Window under security and exchange board of India (PIT) Regulation 2015.
8 months agoWe hereby inform you that the management of the company met with group of investor held by the Hem Securities Samrudhi 2025- Virtual SME Conclave through virtual mode on Thursday December 4 2025.
9 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Oct 2024
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
4th Floor, Asarfi Hospital Baramuri, Bishunpur Polytechnic Dhanbad Jharkhand PIN: 828130 Tel No: 9608833708 Fax No: NULL Email: [email protected] Internet: www.asarfi.in
Registrars
Subramanian Buildings No 1 , Club House Road,,Chennai Subramanian Buildings No 1 Club House Road NULL PIN: Tel No: 044-28460390/28460394 Fax No: 044-28460129 Email: NULL
Management
Sudipa Singh, Company Secretary & Compliance Officer
Udai Pratap Singh, Managing Director
Madhuri Singh, Executive Director
Gopal Singh, Executive Director
Sukanti Kumar Das, Non Executive Director
Amit Kumar Barnwal, Non Executive Independent Director
Rajkumari Sharma, Non Executive Independent Director
Details
BSE 543943
NSE NULL
ISIN INE0DN001027